Omead Ostadan
Chief Executive Officer at Cellanome, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter J. Fromen | M | 49 |
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 2 years |
| Charles Dadswell | M | 65 | 11 years | |
| Ali Agah | M | - |
Cellanome, Inc.
 Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company that specializes in sequencing, microfluidics, and integrated sensors, as well as molecular biology and biochemistry. Cellanome is based in Redwood City, CA. The company has a team of experienced professionals and has partnered with leading life science investors. The CEO of the company is Ali Agah. | - |
| Mostafa Ronaghi | M | 55 |
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company that specializes in sequencing, microfluidics, and integrated sensors, as well as molecular biology and biochemistry. Cellanome is based in Redwood City, CA. The company has a team of experienced professionals and has partnered with leading life science investors. The CEO of the company is Ali Agah. | 16 years |
| David Horn | M | 56 | 4 years | |
| Gail Marcus | M | 67 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Bobby Yerramilli-Rao | M | 58 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 12 years |
| Robert Epstein | M | 69 | 12 years | |
| Meeta Gulyani | F | 55 | 3 years | |
| Rachel Haurwitz | M | 38 | 3 years | |
| Shankar Balasubramanian | M | - |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 12 years |
| Elona Kogan | F | 54 | 4 years | |
| Frances Arnold | M | 67 | 8 years | |
| Caroline Dorsa | F | 64 | 7 years | |
| Dipchand Nishar | M | 55 | 3 years | |
| Susan Siegel | F | 63 | 5 years | |
| Scott Gottlieb | M | 51 | 4 years | |
| Martin Murphy | M | 55 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Gary Guthart | M | 58 | 7 years | |
| Philip Schiller | M | 63 | 8 years | |
| Somu Subramaniam | M | 69 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 10 years |
| Thomas William Hulme | M | 48 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Alice Newcombe-Ellis | F | 41 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | - |
| Fiona Stewart | F | - |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 4 years |
| Roelof Botha | M | 50 |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | 9 years |
| Tarun Kumar Khurana | M | - |
Cellanome, Inc.
Cellanome, Inc. Miscellaneous Commercial ServicesCommercial Services Cellanome, Inc. is a company that specializes in sequencing, microfluidics, and integrated sensors, as well as molecular biology and biochemistry. Cellanome is based in Redwood City, CA. The company has a team of experienced professionals and has partnered with leading life science investors. The CEO of the company is Ali Agah. | - |
| Scott Ericksen | M | 52 | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Walt | M | 71 | 18 years | |
| Francis deSouza | M | 53 | 10 years | |
| Roy A. Whitfield | M | 70 |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 11 years |
| William Rastetter | M | 76 | 18 years | |
| John Stuelpnagel | M | 66 | 11 years | |
| Philip Ma | M | 59 | - | |
| John Thompson | M | 74 | 6 years | |
| Arthur Bowman | M | 77 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 12 years |
| Marc Stapley | M | 54 | 7 years | |
| Nicholas Naclerio | M | 62 | 6 years | |
| Robert Kelley | M | 52 | 7 years | |
| Kathy A. San Roman | F | 70 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 15 years |
| Paul Grint | M | 66 | 8 years | |
| Joydeep Goswami | M | 52 | 5 years | |
| Catherine Friedman | F | 63 | 3 years | |
| Michael Bouchard | M | 57 | - | |
| Kevin Williams | M | - | - | |
| John West | M | 67 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 3 years |
| Daniel Bradbury | M | 62 | 13 years | |
| Karin Eastham | F | 74 | 15 years | |
| Gerald Heinz Möller | M | 80 | 5 years | |
| Karen Possemato | F | - | - | |
| Christian G. Cabou | M | 74 | 7 years | |
| Dalen Meeter | M | 46 | 9 years | |
| Christian Henry | M | 56 | 12 years | |
| Tony Smith | M | 68 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 2 years |
| Matthew Posard | M | 56 | 9 years | |
| AmirAli Talasaz | M | 44 | 1 years | |
| Aimee Hoyt | F | 53 | - | |
| Craig Ciesla | M | 51 | 6 years | |
| Scott Thomas | M | 51 | 1 years | |
| Shashanka Muppaneni | M | - | - | |
| Robert Shoemaker | M | 43 | 1 years | |
| Phillip Febbo | M | 57 | 5 years | |
| Nick Nelson | M | 41 | 10 years | |
| Lakshmi Narayan Mishra | M | 47 | 1 years | |
| Sanjay Chikarmane | M | - | 2 years | |
| Paula Dowdy | F | 58 | 7 years | |
| Sam Samad | M | 54 | 5 years | |
| Neil Ward | M | - | 13 years | |
| Jonathan Seaton | M | 53 | - | |
| Jennifer Maggio | F | - | 2 years | |
| Justin O. Emory | M | 45 | 6 years | |
| Min-Jui Shen | M | 60 | 16 years | |
| Michele Farmer | F | - | 12 years | |
| Emily Winn-Deen | M | - | - | |
| Frank Oaks | M | - |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 1 years |
| William Bonnar | M | - | - | |
| Stephen Benkovic | M | - |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | - |
| Robert Ragusa | M | 64 | 8 years | |
| Tristan B. Orpin | M | 58 | 15 years | |
| Stephen D. Allen | M | 65 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 2 years |
| Peter C. Lundberg | M | 63 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 2 years |
| Linda Rubinstein | F | 58 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 2 years |
| Kirk Malloy | M | 57 | 14 years | |
| Brock Martin Siegel | M | - |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 1 years |
| B. Cimler | M | 66 | - | |
| David Barker | M | 82 | 7 years | |
| Robert C. Kain | M | 63 | 15 years | |
| Alexander Dickinson | M | 62 | 7 years | |
| Jorge Velarde | M | 57 | 11 years | |
| Norman Fjeldheim | M | - | - | |
| Richard Klausner | M | 72 | 3 years | |
| Jacquie Ross | F | - | 4 years | |
| Juliet C. Cunningham | F | - | - | |
| Jack Goldstein | M | 77 | 4 years | |
| Joseph Whitters | M | 66 |
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | 1 years |
| Laura Lauman | F | - | - | |
| Mya Thomae | F | - | 3 years | |
| Helmy Eltoukhy | M | 45 | 4 years | |
| Alex Aravanis | M | 48 | 3 years | |
| Stephen Pentoney | M | - | - | |
| Brandon Poe | M | - | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 91 | 91.00% |
| United Kingdom | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Omead Ostadan
- Personal Network
